<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PGENETICS-D-11-00802</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1002322</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Population biology</subject>
            <subj-group>
              <subject>Epidemiology</subject>
              <subj-group>
                <subject>Genetic epidemiology</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Epidemiology</subject>
            <subj-group>
              <subject>Cardiovascular disease epidemiology</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Public Health and Epidemiology</subject>
        </subj-group>
      </article-categories><title-group><article-title>A Phenomics-Based Strategy Identifies Loci on <italic>APOC1</italic>, <italic>BRAP</italic>, and <italic>PLCG1</italic> Associated with Metabolic Syndrome Phenotype Domains</article-title><alt-title alt-title-type="running-head">Metabolic Phenotype Dimensions GWAS</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Avery</surname>
            <given-names>Christy L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>He</surname>
            <given-names>Qianchuan</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>North</surname>
            <given-names>Kari E.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ambite</surname>
            <given-names>Jose L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Boerwinkle</surname>
            <given-names>Eric</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">
            <sup>5</sup>
          </xref>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Fornage</surname>
            <given-names>Myriam</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">
            <sup>6</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hindorff</surname>
            <given-names>Lucia A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff7">
            <sup>7</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Kooperberg</surname>
            <given-names>Charles</given-names>
          </name>
          <xref ref-type="aff" rid="aff8">
            <sup>8</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Meigs</surname>
            <given-names>James B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff9">
            <sup>9</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Pankow</surname>
            <given-names>James S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff10">
            <sup>10</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Pendergrass</surname>
            <given-names>Sarah A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">
            <sup>11</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Psaty</surname>
            <given-names>Bruce M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff12">
            <sup>12</sup>
          </xref>
          <xref ref-type="aff" rid="aff13">
            <sup>13</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Ritchie</surname>
            <given-names>Marylyn D.</given-names>
          </name>
          <xref ref-type="aff" rid="aff11">
            <sup>11</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Rotter</surname>
            <given-names>Jerome I.</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">
            <sup>14</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Taylor</surname>
            <given-names>Kent D.</given-names>
          </name>
          <xref ref-type="aff" rid="aff14">
            <sup>14</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wilkens</surname>
            <given-names>Lynne R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff15">
            <sup>15</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Heiss</surname>
            <given-names>Gerardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Lin</surname>
            <given-names>Dan Yu</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Epidemiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Biostatistics, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Carolina Center for Genome Sciences, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America</addr-line>       </aff><aff id="aff4"><label>4</label><addr-line>Information Sciences Institute, University of Southern California, Los Angeles, California, United States of America</addr-line>       </aff><aff id="aff5"><label>5</label><addr-line>Division of Epidemiology, The University of Texas Health Science Center, Houston, Texas, United States of America</addr-line>       </aff><aff id="aff6"><label>6</label><addr-line>Center for Human Genetics, The University of Texas Health Science Center, Houston, Texas, United States of America</addr-line>       </aff><aff id="aff7"><label>7</label><addr-line>Office of Population Genomics, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America</addr-line>       </aff><aff id="aff8"><label>8</label><addr-line>Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America</addr-line>       </aff><aff id="aff9"><label>9</label><addr-line>General Medicine Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America</addr-line>       </aff><aff id="aff10"><label>10</label><addr-line>Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, United States of America</addr-line>       </aff><aff id="aff11"><label>11</label><addr-line>Center for Human Genetics Research, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America</addr-line>       </aff><aff id="aff12"><label>12</label><addr-line>Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, Washington, United States of America</addr-line>       </aff><aff id="aff13"><label>13</label><addr-line>Group Health Research Institute, Group Health Cooperative, Seattle, Washington, United States of America</addr-line>       </aff><aff id="aff14"><label>14</label><addr-line>Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States of America</addr-line>       </aff><aff id="aff15"><label>15</label><addr-line>Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Gibson</surname>
            <given-names>Greg</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Georgia Institute of Technology, United States of America</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">christy_avery@unc.edu</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: CLA QH GH DYL. Analyzed the data: CLA QH DYL. Wrote the paper: CLA QH GH DY. Provided genetic data: EB MF JBM JSP BMP JIR KDT GH. Critical review of manuscript: KEN JLA EB MF LAH CK JBM JSP SAP BMP MDR JIR KDT LRW.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <month>10</month>
        <year>2011</year>
      </pub-date><pub-date pub-type="epub">
        <day>13</day>
        <month>10</month>
        <year>2011</year>
      </pub-date><volume>7</volume><issue>10</issue><elocation-id>e1002322</elocation-id><history>
        <date date-type="received">
          <day>19</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>8</month>
          <year>2011</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2011</copyright-year><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.</license-p></license></permissions><abstract>
        <p>Despite evidence of the clustering of metabolic syndrome components, current approaches for identifying unifying genetic mechanisms typically evaluate clinical categories that do not provide adequate etiological information. Here, we used data from 19,486 European American and 6,287 African American Candidate Gene Association Resource Consortium participants to identify loci associated with the clustering of metabolic phenotypes. Six phenotype domains (atherogenic dyslipidemia, vascular dysfunction, vascular inflammation, pro-thrombotic state, central obesity, and elevated plasma glucose) encompassing 19 quantitative traits were examined. Principal components analysis was used to reduce the dimension of each domain such that &gt;55% of the trait variance was represented within each domain. We then applied a statistically efficient and computational feasible multivariate approach that related eight principal components from the six domains to 250,000 imputed SNPs using an additive genetic model and including demographic covariates. In European Americans, we identified 606 genome-wide significant SNPs representing 19 loci. Many of these loci were associated with only one trait domain, were consistent with results in African Americans, and overlapped with published findings, for instance central obesity and <italic>FTO</italic>. However, our approach, which is applicable to any set of interval scale traits that is heritable and exhibits evidence of phenotypic clustering, identified three new loci in or near <italic>APOC1</italic>, <italic>BRAP</italic>, and <italic>PLCG1,</italic> which were associated with multiple phenotype domains. These pleiotropic loci may help characterize metabolic dysregulation and identify targets for intervention.</p>
      </abstract><abstract abstract-type="summary">
        <title>Author Summary</title>
        <p>The metabolic syndrome represents a clustering of metabolic phenotypes (e.g. elevated blood pressure, cholesterol levels, and plasma glucose, as well as abdominal obesity) and is associated with an increased risk of atherosclerosis and type 2 diabetes. Although multiple genes influencing the specific metabolic syndrome components have been reported, few studies have evaluated the genetic underpinnings of the syndrome as a whole. Here, we describe an approach to evaluate multiple clustered traits, which allows us to test whether common genetic variants influence the co-occurrence of one or more metabolic phenotypes. By examining approximately 20,000 European American and 6,200 African American participants from five studies, we show that three regions on chromosomes 12, 19, and 20 are associated with multiple metabolic phenotypes. These genetic variants are highly intriguing candidates that may increase our understanding of the biologic basis of the clustering of metabolic phenotypes and help identify targets for early intervention.</p>
      </abstract><funding-group><funding-statement>PAGE: Support for the Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) was provided through the National Human Genome Research Institute's Population Architecture Using Genomics and Epidemiology (PAGE) network (U01 HG004803). EAGLE work was funded by NIH/NHGRI grant U01 HG004798. The WHI program is funded by NIH/NHLBI, U.S. Department of Health and Human Services, through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221, and U01 HG004790. Funding support for the Multiethnic Cohort study was provided through the National Cancer Institute (R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758) and NHGRI (U01 HG004802). CARe: The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. The following five parent studies contributed parent study data, ancillary study data, and DNA samples through the Broad Institute (N01-HC-65226) to create this genotype/phenotype data base for wide dissemination to the biomedical research community: Atherosclerosis Risk in Communities (ARIC): University of North Carolina at Chapel Hill (N01-HC-55015), Baylor Medical College (N01-HC-55016), University of Mississippi Medical Center (N01-HC-55021), University of Minnesota (N01-HC-55019), Johns Hopkins University (N01-HC-55020), University of Texas, Houston (N01-HC-55017); Cardiovascular Health Study (CHS): University of Washington (N01-HC-85079), Wake Forest University (N01-HC-85080), Johns Hopkins University (N01-HC-85081), University of Pittsburgh (N01-HC-85082), University of California Davis (N01-HC-85083), University of California Irvine (N01-HC-85084), New England Medical Center (N01-HC-85085), University of Vermont (N01-HC-85086), Georgetown University (N01-HC-35129), Johns Hopkins University (N01 HC-15103), University of Wisconsin (N01-HC-75150), Geisinger Clinic (N01-HC-45133), University of Washington (N01 HC-55222, U01 HL080295); Coronary Artery Risk in Young Adults (CARDIA): University of Alabama at Birmingham (N01-HC-48047), University of Minnesota (N01-HC-48048), Northwestern University (N01-HC-48049), Kaiser Foundation Research Institute (N01-HC-48050), University of Alabama at Birmingham (N01-HC-95095), Tufts-New England Medical Center (N01-HC-45204), Wake Forest University (N01-HC-45205), Harbor-UCLA Research and Education Institute (N01-HC-05187), University of California Irvine (N01-HC-45134, N01-HC-95100); Framingham Heart Study (FHS): Boston University (N01-HC-25195); Multi-Ethnic Study of Atherosclerosis (MESA): University of Washington (N01-HC-95159), Regents of the University of California (N01-HC-95160), Columbia University (N01-HC-95161), Johns Hopkins University (N01-HC-95162), University of Minnesota (N01-HC-95163), Northwestern University (N01-HC-95164), Wake Forest University (N01-HC-95165), University of Vermont (N01-HC-95166), New England Medical Center (N01-HC-95167), Johns Hopkins University (N01-HC-95168), Harbor-UCLA Research and Education Institute (N01-HC-95169). CLA was supported by grant K99-HL-098458 from the NHLBI. JBM was supported by grants K24 DK080140 and R01 DK078616 from the NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="11"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>The metabolic syndrome represents metabolic dysregulation expressed as the clustering of several physiologic risk factors and is associated with an increased risk of atherosclerosis and type 2 diabetes <xref ref-type="bibr" rid="pgen.1002322-Isomaa1">[1]</xref>. The core metabolic syndrome domains are abdominal obesity, atherogenic dyslipidemia, elevated blood pressure, elevated plasma glucose, a pro-thrombotic state, and a pro-inflammatory state <xref ref-type="bibr" rid="pgen.1002322-Grundy1">[2]</xref>, which are represented to varying degrees in commonly used metabolic syndrome scoring systems <xref ref-type="bibr" rid="pgen.1002322-Alberti1">[3]</xref>–<xref ref-type="bibr" rid="pgen.1002322-Grundy2">[7]</xref>.</p>
      <p>Several lines of evidence support a genetic basis underlying the core metabolic syndrome domains. Measures of metabolic domains cluster in families <xref ref-type="bibr" rid="pgen.1002322-BosyWestphal1">[8]</xref> and heritability estimates range from 16% for systolic blood pressure to 60% for high-density lipoprotein (HDL) cholesterol <xref ref-type="bibr" rid="pgen.1002322-Lin1">[9]</xref>. Genome-wide association (GWA) studies have also identified common variants in <italic>CETP</italic>, <italic>LPL, APOA5,</italic> and <italic>GCKR</italic> that influence the co-occurrence of metabolic domain phenotypes <xref ref-type="bibr" rid="pgen.1002322-Zabaneh1">[10]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Kraja1">[11]</xref>.</p>
      <p>Despite evidence of the clustering of metabolic domain phenotypes, current approaches for identifying unifying genetic mechanisms (i.e. pleiotropy) remain largely focused on clinical categories that do not provide adequate etiological information <xref ref-type="bibr" rid="pgen.1002322-Muller1">[12]</xref>. As an alternative, a phenomics approach that assembles coherent sets of phenotypic features that extend across individual measurements and diagnostic boundaries creates the opportunity for novel genetic investigations of established biological pathways and complements the traditional GWA study or candidate gene-based strategy focused on individual phenotypes <xref ref-type="bibr" rid="pgen.1002322-Houle1">[13]</xref>–<xref ref-type="bibr" rid="pgen.1002322-Bilder1">[15]</xref>. In addition to making use of existing knowledge on process-related information or pathways, a multi-phenotype phenomics approach also may provide greater statistical power than analyses of individual phenotypes <xref ref-type="bibr" rid="pgen.1002322-Amos1">[16]</xref> and improve the ability to detect effects of small magnitude <xref ref-type="bibr" rid="pgen.1002322-Jiang1">[17]</xref>. Although several authors have advocated the use of such strategies <xref ref-type="bibr" rid="pgen.1002322-Bilder1">[15]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Bilder2">[18]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Freimer1">[19]</xref>, the approach is implemented infrequently.</p>
      <p>This study evaluated evidence of pleiotropy in clustered metabolic domains using data from five well characterized population-based studies composed of approximately 20,000 European American and 6,200 African American participants: the Atherosclerosis Risk in Communities (ARIC) study, the Coronary Artery Risk Development in Young Adults (CARDIA) study, the Cardiovascular Health Study (CHS), the Framingham Heart Study (FHS), and the Multi-Ethnic Study of Atherosclerosis (MESA). Six phenotype domains (atherogenic dyslipidemia, vascular dysfunction, vascular inflammation, pro-thrombotic state, central obesity and elevated plasma glucose) encompassing 19 quantitative traits were examined. After dimension reduction, we applied a statistically efficient and computationally feasible multivariate approach that related the phenotype domains to 250,000 imputed SNPs. Our approach, which is applicable to studies of heritable, clustered interval scale outcomes, identified several genome-wide significant loci associated with multiple phenotype domains, which may help characterize metabolic dysregulation and identify targets for intervention.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <p>After excluding duplicate samples (N = 56), first- and second-degree relatives (N = 1,152) in all studies except the family-based Framingham Heart Study, and individuals identified as genetic outliers (N = 20), there were 19,468 European American and 6,287 African American Candidate Gene Association Resource Consortium (CARe) participants available for analysis. As expected, CARDIA participants (mean age: 25 years) had better cardiovascular health profiles, including lower low density lipoprotein concentrations, markers of vascular inflammation, and blood pressure levels when compared to the older cohorts (<xref ref-type="supplementary-material" rid="pgen.1002322.s002">Tables S1</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s003">S2</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s004">S3</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s005">S4</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s006">S5</xref>).</p>
      <p>Eight principle components were used to characterize the six metabolic syndrome trait domains (<xref ref-type="fig" rid="pgen-1002322-g001">Figure 1</xref>): one principal component each for vascular dysfunction, elevated plasma glucose, pro-thrombotic state and central obesity and two principal components for atherogenic dyslipidemia and vascular inflammation. Correlation between the principal components, which served as the eight phenotypes of interest, was modest and consistent across studies and racial groups. As an example, race- specific results from the ARIC Study are presented in <xref ref-type="supplementary-material" rid="pgen.1002322.s007">Tables S6</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s008">S7</xref>.</p>
      <fig id="pgen-1002322-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1002322.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Variables used to characterize six metabolic syndrome domains.</title>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.g001" xlink:type="simple"/>
      </fig>
      <p>ARIC and CARDIA were the only studies with full phenotype data for all 19 of the variables used to define the metabolic trait domains. Although apolipoprotein A1 and B measurements were unavailable in three cohorts, the high correlations with high-density and low-density lipoprotein concentrations (<italic>r</italic>&gt;0.70 in ARIC data, <xref ref-type="supplementary-material" rid="pgen.1002322.s009">Tables S8</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s010">S9</xref>) suggested that all five cohorts provided similar atherogenic dyslipidemia phenotypes. A similarly high correlation was observed between von Willebrand factor and factor VIII in the ARIC data, implying a common pro-thrombotic phenotype in studies missing either measurement. The modest correlation between systemic markers of inflammation in the MESA study, which did not measure white blood cell count and uric acid concentration, suggests that this study may contribute a slightly different vascular inflammation phenotype. The MESA study also did not assay factor VII, suggesting that this study also contributed a somewhat different pro-thrombotic phenotype. However, a sensitivity analysis excluding pro-thrombotic and inflammation principal components estimated in the MESA study yielded comparable results.</p>
      <p>In European Americans, we identified 606 SNPs representing 19 loci that were associated with at least one metabolic trait domain (<xref ref-type="table" rid="pgen-1002322-t001">Table 1</xref>, <xref ref-type="fig" rid="pgen-1002322-g002">Figure 2</xref>) at the genome-wide significance level (<italic>P</italic>&lt;2.13×10<sup>−7</sup>; the SNP with the lowest <italic>P</italic> – value chosen if multiple significant SNPs were identified for a given locus) and these results were consistent across the multiple large cohorts (<xref ref-type="supplementary-material" rid="pgen.1002322.s011">Table S10</xref> and <xref ref-type="supplementary-material" rid="pgen.1002322.s001">Figure S1</xref>). Several of these loci overlapped results in African Americans (<xref ref-type="table" rid="pgen-1002322-t002">Table 2</xref>, <xref ref-type="fig" rid="pgen-1002322-g003">Figure 3</xref>), including associations with <italic>LPL, ABO, VWF, CTEP,</italic> and <italic>LDLR</italic>. In addition to these 19 loci, we also identified 15 additional secondary signals in European Americans, defined as genome-wide significant SNPs (the SNP with the lowest <italic>P</italic> – value chosen if multiple significant SNPs were identified for a given locus) in very low linkage disequilibrium (LD) (r<sup>2</sup>&lt;0.05) with the most significant SNP and within the same 1,000-kb region (<xref ref-type="supplementary-material" rid="pgen.1002322.s012">Table S11</xref>). To verify the independent contributions of these additional loci, we performed a conditional analysis using the most significant SNP at each significant locus as a covariate. Thirteen of these signals remained significant, including one <italic>APOC1</italic> variant, after adjusting for the primary signals.</p>
      <fig id="pgen-1002322-g002" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1002322.g002</object-id>
        <label>Figure 2</label>
        <caption>
          <title>Multivariate association scan of the metabolic syndrome in n = 19,468 European American participants from five cohorts. Y-axis <italic>P</italic>–values are truncated at 1×10<sup>−20</sup>.</title>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.g002" xlink:type="simple"/>
      </fig>
      <fig id="pgen-1002322-g003" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pgen.1002322.g003</object-id>
        <label>Figure 3</label>
        <caption>
          <title>Multivariate GWAS of metabolic syndrome in n = 6,287 African American participants from four cohorts. Y-axis <italic>P</italic>–values are truncated at 1×10<sup>−20</sup>.</title>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.g003" xlink:type="simple"/>
      </fig>
      <table-wrap id="pgen-1002322-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1002322.t001</object-id><label>Table 1</label><caption>
          <title>Associations for 19 known, confirmed, or possible new loci for metabolic syndrome trait dimensions in n = 19,468 European Americans from five studies.</title>
        </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pgen-1002322-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.t001" xlink:type="simple"/><table>
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="8" rowspan="1">Univariate <italic>P</italic></td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">SNP<xref ref-type="table-fn" rid="nt101">a</xref></td>
              <td align="left" colspan="1" rowspan="1">Gene</td>
              <td align="left" colspan="1" rowspan="1">Distance from gene (kb)</td>
              <td align="left" colspan="1" rowspan="1">Chr</td>
              <td align="left" colspan="1" rowspan="1">Position (build 36)</td>
              <td align="left" colspan="1" rowspan="1">Coded AF</td>
              <td align="left" colspan="1" rowspan="1">Alleles<sup>b</sup></td>
              <td align="left" colspan="1" rowspan="1">MV <italic>P</italic></td>
              <td align="left" colspan="1" rowspan="1">Vascular dysfunction</td>
              <td align="left" colspan="1" rowspan="1">Elevated plasma glucose</td>
              <td align="left" colspan="2" rowspan="1">Atherogenic<underline>Dyslipidemia</underline></td>
              <td align="left" colspan="2" rowspan="1">Vascular<underline>Inflammation</underline></td>
              <td align="left" colspan="1" rowspan="1">Pro-thrombotic state</td>
              <td align="left" colspan="1" rowspan="1">Central Obesity</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1">1</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1">1</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs1713222</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>APOB</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼99.5</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1">21124828</td>
              <td align="left" colspan="1" rowspan="1">0.17</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">6.1×10<sup>−13</sup></td>
              <td align="left" colspan="1" rowspan="1">0.81</td>
              <td align="left" colspan="1" rowspan="1">0.30</td>
              <td align="left" colspan="1" rowspan="1">8.7×10<sup>−13</sup></td>
              <td align="left" colspan="1" rowspan="1">0.026</td>
              <td align="left" colspan="1" rowspan="1">0.27</td>
              <td align="left" colspan="1" rowspan="1">0.65</td>
              <td align="left" colspan="1" rowspan="1">0.29</td>
              <td align="left" colspan="1" rowspan="1">0.89</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs1260326</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>GCKR</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">NSYN</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1">27584444</td>
              <td align="left" colspan="1" rowspan="1">0.43</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">8.1×10<sup>−16</sup></td>
              <td align="left" colspan="1" rowspan="1">0.14</td>
              <td align="left" colspan="1" rowspan="1">1.2×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">2.6×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">0.95</td>
              <td align="left" colspan="1" rowspan="1">0.027</td>
              <td align="left" colspan="1" rowspan="1">0.43</td>
              <td align="left" colspan="1" rowspan="1">0.016</td>
              <td align="left" colspan="1" rowspan="1">0.41</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs579060</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>ABCB11</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1">169491285</td>
              <td align="left" colspan="1" rowspan="1">0.65</td>
              <td align="left" colspan="1" rowspan="1">T/G</td>
              <td align="left" colspan="1" rowspan="1">2.4×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.28</td>
              <td align="left" colspan="1" rowspan="1">4.1×10<sup>−6</sup></td>
              <td align="left" colspan="1" rowspan="1">0.57</td>
              <td align="left" colspan="1" rowspan="1">6.5×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">0.013</td>
              <td align="left" colspan="1" rowspan="1">0.022</td>
              <td align="left" colspan="1" rowspan="1">0.17</td>
              <td align="left" colspan="1" rowspan="1">0.054</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs301</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>LPL</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">8</td>
              <td align="left" colspan="1" rowspan="1">19861214</td>
              <td align="left" colspan="1" rowspan="1">0.76</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">9.5×10<sup>−20</sup></td>
              <td align="left" colspan="1" rowspan="1">0.025</td>
              <td align="left" colspan="1" rowspan="1">8.0×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">1.4×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">7.4×10<sup>−18</sup></td>
              <td align="left" colspan="1" rowspan="1">0.27</td>
              <td align="left" colspan="1" rowspan="1">0.15</td>
              <td align="left" colspan="1" rowspan="1">0.88</td>
              <td align="left" colspan="1" rowspan="1">0.035</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs2954021</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>TRIB1</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">100.6</td>
              <td align="left" colspan="1" rowspan="1">8</td>
              <td align="left" colspan="1" rowspan="1">126551259</td>
              <td align="left" colspan="1" rowspan="1">0.50</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">1.3×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.051</td>
              <td align="left" colspan="1" rowspan="1">0.12</td>
              <td align="left" colspan="1" rowspan="1">1.2×10<sup>−11</sup></td>
              <td align="left" colspan="1" rowspan="1">0.035</td>
              <td align="left" colspan="1" rowspan="1">0.28</td>
              <td align="left" colspan="1" rowspan="1">0.87</td>
              <td align="left" colspan="1" rowspan="1">0.094</td>
              <td align="left" colspan="1" rowspan="1">0.29</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs2575876</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>ABCA1</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">9</td>
              <td align="left" colspan="1" rowspan="1">106705560</td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">6.2×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">0.21</td>
              <td align="left" colspan="1" rowspan="1">0.78</td>
              <td align="left" colspan="1" rowspan="1">0.032</td>
              <td align="left" colspan="1" rowspan="1">1.2×10<sup>−07</sup></td>
              <td align="left" colspan="1" rowspan="1">0.49</td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">0.037</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs687621</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>ABO</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">9</td>
              <td align="left" colspan="1" rowspan="1">135126886</td>
              <td align="left" colspan="1" rowspan="1">0.66</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">&lt;1.0×10<sup>−300</sup></td>
              <td align="left" colspan="1" rowspan="1">0.84</td>
              <td align="left" colspan="1" rowspan="1">0.015</td>
              <td align="left" colspan="1" rowspan="1">4.9×10<sup>−4</sup></td>
              <td align="left" colspan="1" rowspan="1">0.093</td>
              <td align="left" colspan="1" rowspan="1">0.15</td>
              <td align="left" colspan="1" rowspan="1">0.81</td>
              <td align="left" colspan="1" rowspan="1">&lt;1×10<sup>−300</sup></td>
              <td align="left" colspan="1" rowspan="1">0.55</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs964184</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>ZNF259</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">3′UTR</td>
              <td align="left" colspan="1" rowspan="1">11</td>
              <td align="left" colspan="1" rowspan="1">116154127</td>
              <td align="left" colspan="1" rowspan="1">0.86</td>
              <td align="left" colspan="1" rowspan="1">C/G</td>
              <td align="left" colspan="1" rowspan="1">5.5×10<sup>−22</sup></td>
              <td align="left" colspan="1" rowspan="1">0.89</td>
              <td align="left" colspan="1" rowspan="1">0.47</td>
              <td align="left" colspan="1" rowspan="1">1.2×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">1.8×10<sup>−12</sup></td>
              <td align="left" colspan="1" rowspan="1">0.13</td>
              <td align="left" colspan="1" rowspan="1">0.38</td>
              <td align="left" colspan="1" rowspan="1">0.61</td>
              <td align="left" colspan="1" rowspan="1">0.70</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs216318</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>VWF</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">12</td>
              <td align="left" colspan="1" rowspan="1">6009522</td>
              <td align="left" colspan="1" rowspan="1">0.09</td>
              <td align="left" colspan="1" rowspan="1">A/C</td>
              <td align="left" colspan="1" rowspan="1">1.6×10<sup>−7</sup></td>
              <td align="left" colspan="1" rowspan="1">0.61</td>
              <td align="left" colspan="1" rowspan="1">0.68</td>
              <td align="left" colspan="1" rowspan="1">0.053</td>
              <td align="left" colspan="1" rowspan="1">0.36</td>
              <td align="left" colspan="1" rowspan="1">0.78</td>
              <td align="left" colspan="1" rowspan="1">0.68</td>
              <td align="left" colspan="1" rowspan="1">1.9×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.44</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs11065987°</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>BRAP</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼9.9</td>
              <td align="left" colspan="1" rowspan="1">12</td>
              <td align="left" colspan="1" rowspan="1">110556807</td>
              <td align="left" colspan="1" rowspan="1">0.54</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">2.9×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">2.2×10<sup>−4</sup></td>
              <td align="left" colspan="1" rowspan="1">0.016</td>
              <td align="left" colspan="1" rowspan="1">0.72</td>
              <td align="left" colspan="1" rowspan="1">3.1×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">0.86</td>
              <td align="left" colspan="1" rowspan="1">0.17</td>
              <td align="left" colspan="1" rowspan="1">0.078</td>
              <td align="left" colspan="1" rowspan="1">9.7×10<sup>−3</sup></td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs7979473</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>HNF1A</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">12</td>
              <td align="left" colspan="1" rowspan="1">119904643</td>
              <td align="left" colspan="1" rowspan="1">0.41</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">1.1×10<sup>−9</sup></td>
              <td align="left" colspan="1" rowspan="1">0.17</td>
              <td align="left" colspan="1" rowspan="1">0.58</td>
              <td align="left" colspan="1" rowspan="1">0.16</td>
              <td align="left" colspan="1" rowspan="1">1.4×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">2.6×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">0.55</td>
              <td align="left" colspan="1" rowspan="1">0.012</td>
              <td align="left" colspan="1" rowspan="1">0.64</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs510335</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>F7</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">5′UTR</td>
              <td align="left" colspan="1" rowspan="1">13</td>
              <td align="left" colspan="1" rowspan="1">112807756</td>
              <td align="left" colspan="1" rowspan="1">0.13</td>
              <td align="left" colspan="1" rowspan="1">T/G</td>
              <td align="left" colspan="1" rowspan="1">1.0×10<sup>−35</sup></td>
              <td align="left" colspan="1" rowspan="1">0.88</td>
              <td align="left" colspan="1" rowspan="1">0.88</td>
              <td align="left" colspan="1" rowspan="1">0.84</td>
              <td align="left" colspan="1" rowspan="1">0.28</td>
              <td align="left" colspan="1" rowspan="1">0.20</td>
              <td align="left" colspan="1" rowspan="1">0.57</td>
              <td align="left" colspan="1" rowspan="1">4.9×10<sup>−49</sup></td>
              <td align="left" colspan="1" rowspan="1">0.92</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs397923</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>LIPC</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼35.1</td>
              <td align="left" colspan="1" rowspan="1">15</td>
              <td align="left" colspan="1" rowspan="1">56479410</td>
              <td align="left" colspan="1" rowspan="1">0.42</td>
              <td align="left" colspan="1" rowspan="1">A/T</td>
              <td align="left" colspan="1" rowspan="1">1.6×10<sup>−15</sup></td>
              <td align="left" colspan="1" rowspan="1">0.02</td>
              <td align="left" colspan="1" rowspan="1">0.063</td>
              <td align="left" colspan="1" rowspan="1">0.19</td>
              <td align="left" colspan="1" rowspan="1">7.1×10<sup>−18</sup></td>
              <td align="left" colspan="1" rowspan="1">0.91</td>
              <td align="left" colspan="1" rowspan="1">0.57</td>
              <td align="left" colspan="1" rowspan="1">0.73</td>
              <td align="left" colspan="1" rowspan="1">0.11</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs9923233</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>FTO</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">16</td>
              <td align="left" colspan="1" rowspan="1">52376699</td>
              <td align="left" colspan="1" rowspan="1">0.41</td>
              <td align="left" colspan="1" rowspan="1">C/G</td>
              <td align="left" colspan="1" rowspan="1">4.9×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.071</td>
              <td align="left" colspan="1" rowspan="1">4.3×10<sup>−5</sup></td>
              <td align="left" colspan="1" rowspan="1">0.75</td>
              <td align="left" colspan="1" rowspan="1">0.67</td>
              <td align="left" colspan="1" rowspan="1">0.098</td>
              <td align="left" colspan="1" rowspan="1">0.63</td>
              <td align="left" colspan="1" rowspan="1">0.086</td>
              <td align="left" colspan="1" rowspan="1">1.7×10<sup>−12</sup></td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs247616</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>CETP</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼6.7</td>
              <td align="left" colspan="1" rowspan="1">16</td>
              <td align="left" colspan="1" rowspan="1">55547091</td>
              <td align="left" colspan="1" rowspan="1">0.33</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">8.3×10<sup>−72</sup></td>
              <td align="left" colspan="1" rowspan="1">0.48</td>
              <td align="left" colspan="1" rowspan="1">0.53</td>
              <td align="left" colspan="1" rowspan="1">7.1×10<sup>−6</sup></td>
              <td align="left" colspan="1" rowspan="1">5×10<sup>−61</sup></td>
              <td align="left" colspan="1" rowspan="1">0.42</td>
              <td align="left" colspan="1" rowspan="1">0.49</td>
              <td align="left" colspan="1" rowspan="1">0.46</td>
              <td align="left" colspan="1" rowspan="1">0.86</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs6511720</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>LDLR</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">19</td>
              <td align="left" colspan="1" rowspan="1">11063306</td>
              <td align="left" colspan="1" rowspan="1">0.12</td>
              <td align="left" colspan="1" rowspan="1">T/G</td>
              <td align="left" colspan="1" rowspan="1">8.3×10<sup>−28</sup></td>
              <td align="left" colspan="1" rowspan="1">0.75</td>
              <td align="left" colspan="1" rowspan="1">0.76</td>
              <td align="left" colspan="1" rowspan="1">5.2×10<sup>−30</sup></td>
              <td align="left" colspan="1" rowspan="1">0.034</td>
              <td align="left" colspan="1" rowspan="1">0.93</td>
              <td align="left" colspan="1" rowspan="1">0.38</td>
              <td align="left" colspan="1" rowspan="1">0.68</td>
              <td align="left" colspan="1" rowspan="1">0.46</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs10401969</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>SUGP1</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">19</td>
              <td align="left" colspan="1" rowspan="1">19268718</td>
              <td align="left" colspan="1" rowspan="1">0.93</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">1.1×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.17</td>
              <td align="left" colspan="1" rowspan="1">0.16</td>
              <td align="left" colspan="1" rowspan="1">1.4×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">0.37</td>
              <td align="left" colspan="1" rowspan="1">2.2×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">0.86</td>
              <td align="left" colspan="1" rowspan="1">0.67</td>
              <td align="left" colspan="1" rowspan="1">0.78</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs4420638°</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>APOC1</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼0.32</td>
              <td align="left" colspan="1" rowspan="1">19</td>
              <td align="left" colspan="1" rowspan="1">50114786</td>
              <td align="left" colspan="1" rowspan="1">0.82</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">1.7×10<sup>−57</sup></td>
              <td align="left" colspan="1" rowspan="1">0.87</td>
              <td align="left" colspan="1" rowspan="1">8.7×10<sup>−4</sup></td>
              <td align="left" colspan="1" rowspan="1">1×10<sup>−31</sup></td>
              <td align="left" colspan="1" rowspan="1">0.91</td>
              <td align="left" colspan="1" rowspan="1">5×10<sup>−12</sup></td>
              <td align="left" colspan="1" rowspan="1">0.38</td>
              <td align="left" colspan="1" rowspan="1">0.015</td>
              <td align="left" colspan="1" rowspan="1">1.2×10<sup>−6</sup></td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs753381°</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>PLCG1</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">NSYN</td>
              <td align="left" colspan="1" rowspan="1">20</td>
              <td align="left" colspan="1" rowspan="1">39230879</td>
              <td align="left" colspan="1" rowspan="1">0.45</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">4.3×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">0.03</td>
              <td align="left" colspan="1" rowspan="1">1.2×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">0.012</td>
              <td align="left" colspan="1" rowspan="1">0.16</td>
              <td align="left" colspan="1" rowspan="1">0.025</td>
              <td align="left" colspan="1" rowspan="1">0.28</td>
              <td align="left" colspan="1" rowspan="1">0.01</td>
            </tr>
          </tbody>
        </table></alternatives><table-wrap-foot>
          <fn id="nt101">
            <label>a</label>
            <p>The most significant SNP for each locus is presented. <sup>b</sup>Coded allele is listed first. AF, allele frequency. <sup>c</sup>Novel locus. Chr, chromosome. MV, multivariate. NSYN, non-synonymous. UTR, untranslated region.</p>
          </fn>
        </table-wrap-foot></table-wrap>
      <table-wrap id="pgen-1002322-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1002322.t002</object-id><label>Table 2</label><caption>
          <title>Associations for 9 known, confirmed, or possible new loci for metabolic syndrome trait dimensions in 6,287 African American participants from four studies.</title>
        </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pgen-1002322-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.t002" xlink:type="simple"/><table>
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
            <col align="center" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="8" rowspan="1">Univariate <italic>P</italic></td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">SNP</td>
              <td align="left" colspan="1" rowspan="1">Gene</td>
              <td align="left" colspan="1" rowspan="1">Distance from gene (kb)</td>
              <td align="left" colspan="1" rowspan="1">Chr</td>
              <td align="left" colspan="1" rowspan="1">Position (build 36)</td>
              <td align="left" colspan="1" rowspan="1">Coded AF</td>
              <td align="left" colspan="1" rowspan="1">Alleles<sup>a</sup></td>
              <td align="left" colspan="1" rowspan="1">MV <italic>P</italic></td>
              <td align="left" colspan="1" rowspan="1">Vascular dysfunction</td>
              <td align="left" colspan="1" rowspan="1">Elevated plasma glucose</td>
              <td align="left" colspan="2" rowspan="1">Atherogenic<underline>Dyslipidemia</underline></td>
              <td align="left" colspan="2" rowspan="1">Vascular<underline>Inflammation</underline></td>
              <td align="left" colspan="1" rowspan="1">Pro-thrombotic state</td>
              <td align="left" colspan="1" rowspan="1">Central Obesity</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1">1</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1">1</td>
              <td align="left" colspan="1" rowspan="1">2</td>
              <td align="left" colspan="1" rowspan="1"/>
              <td align="left" colspan="1" rowspan="1"/>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs12740374</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>CELSR2</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">3′UTR</td>
              <td align="left" colspan="1" rowspan="1">1</td>
              <td align="left" colspan="1" rowspan="1">109619113</td>
              <td align="left" colspan="1" rowspan="1">0.25</td>
              <td align="left" colspan="1" rowspan="1">T/G</td>
              <td align="left" colspan="1" rowspan="1">3.6×10<sup>−13</sup></td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">0.80</td>
              <td align="left" colspan="1" rowspan="1">8.0×10<sup>−16</sup></td>
              <td align="left" colspan="1" rowspan="1">0.30</td>
              <td align="left" colspan="1" rowspan="1">0.32</td>
              <td align="left" colspan="1" rowspan="1">0.20</td>
              <td align="left" colspan="1" rowspan="1">0.058</td>
              <td align="left" colspan="1" rowspan="1">0.27</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs2592887</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>CRP</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼29.1</td>
              <td align="left" colspan="1" rowspan="1">1</td>
              <td align="left" colspan="1" rowspan="1">157919563</td>
              <td align="left" colspan="1" rowspan="1">0.45</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">8.4×10<sup>−8</sup></td>
              <td align="left" colspan="1" rowspan="1">0.62</td>
              <td align="left" colspan="1" rowspan="1">0.64</td>
              <td align="left" colspan="1" rowspan="1">0.77</td>
              <td align="left" colspan="1" rowspan="1">0.17</td>
              <td align="left" colspan="1" rowspan="1">2.8×10<sup>−7</sup></td>
              <td align="left" colspan="1" rowspan="1">0.79</td>
              <td align="left" colspan="1" rowspan="1">0.90</td>
              <td align="left" colspan="1" rowspan="1">7.0×10<sup>−3</sup></td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs3211938</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>CD36</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">NSYN</td>
              <td align="left" colspan="1" rowspan="1">7</td>
              <td align="left" colspan="1" rowspan="1">80138385</td>
              <td align="left" colspan="1" rowspan="1">0.91</td>
              <td align="left" colspan="1" rowspan="1">T/G</td>
              <td align="left" colspan="1" rowspan="1">4.8×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.39</td>
              <td align="left" colspan="1" rowspan="1">0.083</td>
              <td align="left" colspan="1" rowspan="1">0.72</td>
              <td align="left" colspan="1" rowspan="1">9.4×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">9.0×10<sup>−4</sup></td>
              <td align="left" colspan="1" rowspan="1">0.19</td>
              <td align="left" colspan="1" rowspan="1">4.8×10<sup>−3</sup></td>
              <td align="left" colspan="1" rowspan="1">0.76</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs10096633</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>LPL</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼32.9</td>
              <td align="left" colspan="1" rowspan="1">8</td>
              <td align="left" colspan="1" rowspan="1">19875201</td>
              <td align="left" colspan="1" rowspan="1">0.41</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">1.8×10<sup>−12</sup></td>
              <td align="left" colspan="1" rowspan="1">0.60</td>
              <td align="left" colspan="1" rowspan="1">0.59</td>
              <td align="left" colspan="1" rowspan="1">0.88</td>
              <td align="left" colspan="1" rowspan="1">1.1×10<sup>−15</sup></td>
              <td align="left" colspan="1" rowspan="1">0.66</td>
              <td align="left" colspan="1" rowspan="1">0.31</td>
              <td align="left" colspan="1" rowspan="1">0.68</td>
              <td align="left" colspan="1" rowspan="1">0.99</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs8176693</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>ABO</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">9</td>
              <td align="left" colspan="1" rowspan="1">135127478</td>
              <td align="left" colspan="1" rowspan="1">0.10</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">6.1×10<sup>−75</sup></td>
              <td align="left" colspan="1" rowspan="1">0.20</td>
              <td align="left" colspan="1" rowspan="1">0.05</td>
              <td align="left" colspan="1" rowspan="1">0.54</td>
              <td align="left" colspan="1" rowspan="1">0.12</td>
              <td align="left" colspan="1" rowspan="1">0.29</td>
              <td align="left" colspan="1" rowspan="1">0.55</td>
              <td align="left" colspan="1" rowspan="1">&lt;1×10<sup>−300</sup></td>
              <td align="left" colspan="1" rowspan="1">0.098</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs2229446</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>VWF</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">NSYN</td>
              <td align="left" colspan="1" rowspan="1">12</td>
              <td align="left" colspan="1" rowspan="1">5973333</td>
              <td align="left" colspan="1" rowspan="1">0.18</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">9.0×10<sup>−9</sup></td>
              <td align="left" colspan="1" rowspan="1">0.29</td>
              <td align="left" colspan="1" rowspan="1">0.46</td>
              <td align="left" colspan="1" rowspan="1">0.78</td>
              <td align="left" colspan="1" rowspan="1">0.30</td>
              <td align="left" colspan="1" rowspan="1">0.45</td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">6.3×10<sup>−11</sup></td>
              <td align="left" colspan="1" rowspan="1">0.91</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs247616</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>CETP</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">∼6.7</td>
              <td align="left" colspan="1" rowspan="1">16</td>
              <td align="left" colspan="1" rowspan="1">55547091</td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
              <td align="left" colspan="1" rowspan="1">T/C</td>
              <td align="left" colspan="1" rowspan="1">1.9×10<sup>−23</sup></td>
              <td align="left" colspan="1" rowspan="1">0.64</td>
              <td align="left" colspan="1" rowspan="1">0.80</td>
              <td align="left" colspan="1" rowspan="1">0.20</td>
              <td align="left" colspan="1" rowspan="1">3.5×10<sup>−23</sup></td>
              <td align="left" colspan="1" rowspan="1">0.02</td>
              <td align="left" colspan="1" rowspan="1">0.34</td>
              <td align="left" colspan="1" rowspan="1">0.49</td>
              <td align="left" colspan="1" rowspan="1">0.26</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs6511720</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>LDLR</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">19</td>
              <td align="left" colspan="1" rowspan="1">11063306</td>
              <td align="left" colspan="1" rowspan="1">0.14</td>
              <td align="left" colspan="1" rowspan="1">T/G</td>
              <td align="left" colspan="1" rowspan="1">2.5×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.94</td>
              <td align="left" colspan="1" rowspan="1">0.10</td>
              <td align="left" colspan="1" rowspan="1">9.5×10<sup>−12</sup></td>
              <td align="left" colspan="1" rowspan="1">0.096</td>
              <td align="left" colspan="1" rowspan="1">0.069</td>
              <td align="left" colspan="1" rowspan="1">0.60</td>
              <td align="left" colspan="1" rowspan="1">0.27</td>
              <td align="left" colspan="1" rowspan="1">0.92</td>
            </tr>
            <tr>
              <td align="left" colspan="1" rowspan="1">rs7254892</td>
              <td align="left" colspan="1" rowspan="1">
                <italic>PVRL2</italic>
              </td>
              <td align="left" colspan="1" rowspan="1">Intronic</td>
              <td align="left" colspan="1" rowspan="1">19</td>
              <td align="left" colspan="1" rowspan="1">50081436</td>
              <td align="left" colspan="1" rowspan="1">0.07</td>
              <td align="left" colspan="1" rowspan="1">A/G</td>
              <td align="left" colspan="1" rowspan="1">1.3×10<sup>−10</sup></td>
              <td align="left" colspan="1" rowspan="1">0.22</td>
              <td align="left" colspan="1" rowspan="1">0.46</td>
              <td align="left" colspan="1" rowspan="1">2.0×10<sup>−11</sup></td>
              <td align="left" colspan="1" rowspan="1">0.093</td>
              <td align="left" colspan="1" rowspan="1">0.88</td>
              <td align="left" colspan="1" rowspan="1">0.88</td>
              <td align="left" colspan="1" rowspan="1">0.09</td>
              <td align="left" colspan="1" rowspan="1">0.30</td>
            </tr>
          </tbody>
        </table></alternatives><table-wrap-foot>
          <fn id="nt102">
            <label/>
            <p><bold>a</bold> Coded allele is listed first. AF, allele frequency. Chr, chromosome. MV, multivariate. NSYN, non-synonymous. UTR, untranslated region.</p>
          </fn>
        </table-wrap-foot></table-wrap>
      <sec id="s2a">
        <title>Previously identified loci associated with single metabolic trait domains</title>
        <p>The strongest signal for both European American and African American participants was located on chromosome 9 in the <italic>ABO</italic> gene (<italic>P</italic>&lt;1.0×10<sup>−300</sup> and <italic>P</italic> = 6.1×10<sup>−75</sup>, respectively). These signals overlap earlier findings between factor VIII and von Willebrand factor with <italic>ABO</italic> <xref ref-type="bibr" rid="pgen.1002322-Smith1">[20]</xref>. Nine additional loci in European Americans and eight loci in African Americans demonstrated effects limited to one metabolic syndrome trait domain that have already been reported in the GWA literature and are therefore not considered further: <italic>ABCA1, APOB</italic>, <italic>CD36, CELSR2, CETP, CRP, F7, LDLR, LIPC, PVRL2, TRIB1, VWF,</italic> and <italic>ZNF259.</italic></p>
      </sec>
      <sec id="s2b">
        <title>Previously identified loci associated multiple trait domains</title>
        <p>Six loci were <italic>associated</italic> with at least two trait domains in European Americans: <italic>GCKR, ABCB11, LPL, HNF1A, FTO,</italic> and <italic>SUGP1,</italic> results which overlap published associations identified through GWA studies for individual trait components. For example, several GWA studies have identified associations between <italic>GCKR</italic> and elevated plasma glucose <xref ref-type="bibr" rid="pgen.1002322-Dupuis1">[21]</xref>, atherogenic dyslipidemia <xref ref-type="bibr" rid="pgen.1002322-Waterworth1">[22]</xref>, and vascular inflammation <xref ref-type="bibr" rid="pgen.1002322-Ridker1">[23]</xref>–<xref ref-type="bibr" rid="pgen.1002322-Kolz1">[25]</xref>. <italic>GCKR</italic> is a plausible unifying mechanism for the clustering of metabolic domains, as the protein inhibits glucokinase, the predominant glucose phosphorylating enzyme <xref ref-type="bibr" rid="pgen.1002322-Matschinsky1">[26]</xref>. <italic>HNF1A</italic>, which encodes the transcription factor hepatocyte nuclear factor (HNF)-1a, also suggests a common pathogenic background, as previous GWA studies have identified associations with atherogenic dyslipidemia <xref ref-type="bibr" rid="pgen.1002322-Kathiresan1">[27]</xref>, vascular inflammation <xref ref-type="bibr" rid="pgen.1002322-Okada1">[28]</xref>, and type 2 diabetes <xref ref-type="bibr" rid="pgen.1002322-Voight1">[29]</xref>. Of note, <italic>FTO</italic> was the only previously identified and consistently replicated obesity locus we identified.</p>
      </sec>
      <sec id="s2c">
        <title>Candidate genes at new loci</title>
        <p>The strongest new pleiotropic signal in European Americans was for rs4420638 (<italic>P</italic> 1.7×10<sup>−57</sup>), located approximately 0.32 kilobases (kb) downstream of <italic>APOC1</italic> and associated with elevated plasma glucose (<italic>P</italic> = 8.7×10<sup>−4</sup>), atherogenic dyslipidemia (1×10<sup>−31</sup>), vascular inflammation (<italic>P</italic> = 5×10<sup>−12</sup>), and central obesity (<italic>P</italic> = 1.2×10<sup>−6</sup>). Although associations between <italic>APOC1</italic> with atherogenic dyslipidemia <xref ref-type="bibr" rid="pgen.1002322-Waterworth1">[22]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Willer1">[30]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Kathiresan2">[31]</xref> and vascular inflammation <xref ref-type="bibr" rid="pgen.1002322-Elliott1">[32]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Dehghan1">[33]</xref> have been reported and replicated in the GWA study literature, we consider it a novel locus due to the strong and previously unreported associations with elevated plasma glucose and central obesity. Localizing this signal is challenging, as the region contains a 48-kb gene cluster that also includes the <italic>APOE</italic> and pseudo-<italic>APOC’</italic> genes <xref ref-type="bibr" rid="pgen.1002322-Li1">[34]</xref>. However, the modest levels of linkage disequilibrium (<xref ref-type="fig" rid="pgen-1002322-g004">Figure 4</xref>), the presence of a second signal (<xref ref-type="supplementary-material" rid="pgen.1002322.s012">Table S11</xref>), studies which demonstrate that mice overexpressing human <italic>APOC1</italic> show a marked reduction in the update of fatty acids into adipocytes <xref ref-type="bibr" rid="pgen.1002322-Jong1">[35]</xref>, and the fact the physiological role of <italic>APOC1</italic> is less well established than <italic>APOE, APOB,</italic> and <italic>APOA1</italic> <xref ref-type="bibr" rid="pgen.1002322-Soutar1">[36]</xref> all support further evaluation and fine mapping of <italic>APOC1.</italic></p>
        <fig id="pgen-1002322-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pgen.1002322.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Regional association plots for metabolic syndrome trait dimensions associated with <italic>APOC1</italic>, <italic>BRAP</italic>, and <italic>PLCG1</italic>.</title>
            <p>Positions are from NCBI build 36 and recombination rates are estimated from HapMap phase II CEU data. SNPs are represented by <italic>circles</italic>, and the <italic>large blue diamond</italic> is the SNP with the lowest <italic>P-</italic>value. Circle color represents correlation with the top SNP: <italic>blue</italic> indicates weak correlation and <italic>red</italic> indicates strong correlation. Recombination rate is plotted in the background and known genes in the region are shown at the bottom of the plot.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.g004" xlink:type="simple"/>
        </fig>
        <p>The second new locus was rs11065987 (<italic>P</italic> = 2.9×10<sup>−10</sup>), located approximately 9.9 kb upstream of <italic>BRAP</italic> and associated with atherogenic dyslipidemia (3.1×10<sup>−3</sup>), vascular dysfunction (2.2×10<sup>−4</sup>), and central obesity (9.7×10<sup>−3</sup>). Initial reports suggested that the <italic>BRAP</italic> protein binds the breast cancer suppressor protein <italic>BRCA1</italic> <xref ref-type="bibr" rid="pgen.1002322-Li2">[37]</xref>. <italic>BRAP</italic> is also known to modulate mitogen activated protein kinase signaling <xref ref-type="bibr" rid="pgen.1002322-Matheny1">[38]</xref>, an established cell survival, growth, differentiation, transformation, and proinflammatory pathway <xref ref-type="bibr" rid="pgen.1002322-Ory1">[39]</xref>.</p>
        <p>The GWA study literature provides few clues that link <italic>BRAP</italic> with metabolic trait domains, as associations have only been identified for alanine aminotransferase <xref ref-type="bibr" rid="pgen.1002322-Kamatani1">[24]</xref> and esophageal cancer <xref ref-type="bibr" rid="pgen.1002322-Cui1">[40]</xref>, both in populations of Japanese descent. However, the recombination rate (cM/Mb) is low from approximately 110.3 Mb to 111.5 Mb (<xref ref-type="fig" rid="pgen-1002322-g004">Figure 4</xref>) and this extended region includes loci associated with type 1 diabetes <xref ref-type="bibr" rid="pgen.1002322-Barrett1">[41]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Cooper1">[42]</xref>, vascular dysfunction <xref ref-type="bibr" rid="pgen.1002322-Levy1">[43]</xref>, and waist-hip ratio <xref ref-type="bibr" rid="pgen.1002322-Cho1">[44]</xref>. The <italic>ATXN2</italic> gene, located 27 kb from the index SNP, is an intriguing candidate gene. Expansion of a CAG repeat in the ataxin-2 protein causes the neurodegenerative disease spinocerebellar ataxia type 2. However, instead of a neurodegenerative phenotype, <italic>ATXN2-</italic>deficient rodents exhibited phenotypes characterized by abdominal obesity, insulin resistance, and marked hepatosteatosis (i.e. lipid accumulation in the liver) <xref ref-type="bibr" rid="pgen.1002322-LastresBecker1">[45]</xref>. Linkage studies of obesity in humans have also associated this region with BMI and total fat percentage <xref ref-type="bibr" rid="pgen.1002322-Li3">[46]</xref>.</p>
        <p>A third genome-wide significant signal was identified for rs753381 (<italic>P</italic> = 4.3×10<sup>−8</sup>), a missense mutation in <italic>PLCG1</italic> that results in a change from an isoleucine to a threonine. <italic>PLCG1</italic> encodes a protein that catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate and plays an important role in the intracellular transduction of receptor-mediated tyrosine kinase activators <xref ref-type="bibr" rid="pgen.1002322-Berridge1">[47]</xref>. Few epidemiologic studies of <italic>PLCG1</italic> or neighboring genes have been published. However, mice nullizygous for <italic>PLCG1</italic> stop growing mid-gestation and show no evidence of vasculogenesis <xref ref-type="bibr" rid="pgen.1002322-Liao1">[48]</xref>. Vasculogenesis has been associated with insulin resistance <xref ref-type="bibr" rid="pgen.1002322-He1">[49]</xref>, plasminogen activator inhibitor-1(PAI-1) concentration <xref ref-type="bibr" rid="pgen.1002322-Xiang1">[50]</xref>, hyperglycemia, and adiponectin levels <xref ref-type="bibr" rid="pgen.1002322-Mouquet1">[51]</xref>. This suggests that <italic>PLCG1</italic> may contribute to the clustering of metabolic domains in a more subtle manner, such as through small alterations in the structure of the <italic>PLCG1</italic> protein. Thus, the missense mutation we identified would serve as a highly intriguing candidate SNP for further study.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>In this study composed of approximately 20,000 European American and 6,200 African American participants, we identified three new loci associated with multiple metabolic trait domains: <italic>APOC1, BRAP,</italic> and <italic>PLCG1</italic>. These loci were in or near genes previously associated with atherogenic dyslipidemia, vascular inflammation, type I diabetes, vascular dysfunction, and central adiposity. No previous genome-wide or gene-centric studies examining evidence for pleiotropy in metabolic domains has detected these loci at genome-wide significant levels.</p>
      <p>The pathogenesis of the clustering of metabolic phenotypes remains poorly understood, although it is likely that a sedentary lifestyle, combined with dietary patterns and genetic susceptibility factors, contribute. Candidate genes associated with metabolic syndrome phenotypes largely reflect current knowledge of established pathways regulating obesity, free fatty acid metabolism, insulin sensitivity, lipid metabolism, and inflammation. Although candidate gene and GWA studies have successfully identified loci influencing variation in these pathways, studies examining genetic factors influencing the co-occurrence of metabolic phenotypes are limited. Additionally, those that examine the clustering of syndromic components using the pre-defined clinical cutpoints are largely inconsistent or inconclusive. This general lack of success may reflect ongoing controversy over metabolic syndrome definitions, leading to phenotypic heterogeneity and inconsistent genetic findings across studies <xref ref-type="bibr" rid="pgen.1002322-Pollex1">[52]</xref>. The utility of studying the syndrome as a binary entity as opposed to a series of component traits is also debated <xref ref-type="bibr" rid="pgen.1002322-Muller1">[12]</xref>, especially since the dichotomization of interval scale traits will discard information.</p>
      <p>Methods for examining evidence of pleiotropy remain uncommon in the GWA literature and most likely reflect the lack of methodologies and software that are scalable to GWA studies. In this paper, we present a statistically efficient and computational feasible approach to testing for pleiotropy on a genome-wide scale. Our method is applicable to population-based and family studies and identified several associations that would not have been identified through typical univariate analyses. The approach presented herein is also not limited to metabolic phenotypes. Instead, our method could be applied to any set of interval scale traits that are heritable and exhibit evidence of phenotypic clustering.</p>
      <p>Although alternative analytic approaches were available, for example estimating principal components for all traits simultaneously, we focused on the phenotype clusters presented in <xref ref-type="fig" rid="pgen-1002322-g001">Figure 1</xref>. First, evaluating the nineteen phenotypes of interest as six domains of interest is biologically plausible given evidence of phenotypic clustering. It was also easier to interpret principal components that were derived in separate phenotype domains rather than components estimated simultaneously. Additionally, estimating principal components within each phenotype domains ensured that each domain was sufficiently represented in the analysis.</p>
      <p>Challenges to the approach presented herein include careful phenotype curation, made more difficult by the inclusion of 19 traits across multiple cohorts that were not measured with a common protocol. Only the ARIC and CARDIA studies had full phenotype information on all 19 traits and CHS was the only study with all traits measured during a single visit. The use of a multivariate phenotype comprised of 19 variables also limited the number of contributing cohorts and the identification of replication cohorts, as few studies have such comprehensive phenotypic data. Nonetheless, we were able to identify approximately 25,000 participants from studies that used standardized, comparable protocols and many of the associations were consistent across cohorts.</p>
      <p>Further challenges that are not unique to large scale genetic studies incorporating a phenomics approach include the consistency of results across populations defined by age, race, sex, or other demographic characteristics. For example, the three new loci identified in the European American population were not detected in the African American population. Given a modest sample size of 6,287 participants it is difficult to determine whether an inability to generalize results to the African American population reflects different patterns of LD, varying environmental contexts, or limited statistical power. Variation in mean age between contributing cohorts, which ranged from 25 years in the CARDIA study to 72 years in the CHS, could introduce additional heterogeneity, as associations between metabolic phenotypes have been shown to diminish with age <xref ref-type="bibr" rid="pgen.1002322-Meigs1">[53]</xref>. Finally, marked variation in the prevalence of the metabolic syndrome by gender, regardless of clinical definition, suggest the possibility of sex-specific metabolic syndrome effects <xref ref-type="bibr" rid="pgen.1002322-Meigs2">[54]</xref>. Analyses that examine modification by sex, age, and other important clinical covariates are therefore warranted.</p>
      <p>Our use of the IBC array, which is composed of variants implicated in cardiovascular, inflammatory, hemostasis/coagulation, and metabolic pathways, was beneficial in that it allowed us to leverage the wealth of information on pathways implicated in metabolic disturbances while reducing multiple testing penalties. Admittedly this approach was limited in that it potentially excludes novel pathways not captured by the IBC chip. Although imputation allowed us to increase the number of variants, genome-wide approaches might identify additional pleiotropic loci.</p>
      <p>In summary, our results support phenomics as a complementary approach that leverages phenotypic variation for the evaluation of pleiotropy, a clear limitation of existing studies examining the metabolic syndrome using clinical definitions. Our approach, which is applicable to studies of heritable, clustered interval scale outcomes, also takes advantage of the wealth of phenotype data available in longitudinal cohort studies as well as emerging analytical and bioinformatics approaches. Ultimately, these results support the presence of genetic variants with pleiotropic effects on adiposity, inflammation, glucose regulation, dyslipidemia, vascular dysfunction and thrombosis. Such loci may help characterize metabolic dysregulation and identify targets for intervention.</p>
    </sec>
    <sec id="s4" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title>Study population</title>
        <p>This study arose from a collaboration between investigators from two National Institute of Health funded consortia examining the genetic basis of common complex diseases: the Population Architecture using Genomics and Epidemiology (PAGE) study, a National Human Genome Research Institute funded effort examining the epidemiologic architecture of common genetic variation that have been reproducibly associated with human diseases and traits <xref ref-type="bibr" rid="pgen.1002322-Matise1">[55]</xref> and the CARe Consortium <xref ref-type="bibr" rid="pgen.1002322-Musunuru1">[56]</xref>, a National Heart, Lung, and Blood Institute-supported resource for genetic analyses examining cardiovascular phenotypes. Briefly, PAGE investigators participating in the phenomics working group wanted to extend existing efforts examining evidence for pleiotropy in approximately 300 replicated genetic variants <xref ref-type="bibr" rid="pgen.1002322-Pendergrass1">[57]</xref> to include a more comprehensive evaluation of common SNPs. A collaboration between PAGE and CARe investigators was therefore initiated, and used data from five CARe studies of European American and African American with adequate phenotype data: ARIC, CARDIA, CHS, FHS, and MESA. All participating institutions and CARe sites obtained Institutional Review Board approval for this study. Additional information on the participating CARe studies is provided in <xref ref-type="supplementary-material" rid="pgen.1002322.s023">Text S1</xref>.</p>
      </sec>
      <sec id="s4b">
        <title>Genotyping</title>
        <p>The Institute for the Translational Medicine and Therapeutics (ITMAT)-Broad-CARe (IBC) genotyping array <xref ref-type="bibr" rid="pgen.1002322-Keating1">[58]</xref> was used to evaluate approximately 2,100 genes related to cardiovascular, inflammatory, hemostasis/coagulation, and metabolic phenotypes and pathways. The IBC array tagging approach was designed to capture maximal genetic information for both common and lower frequency SNPs (&lt;5% minor allele frequency (MAF)) in HapMap as well as European American and African American populations. The array included 49,320 SNPs, 15,000 of which were gene variants not present in HapMap. Additional details of the SNP selection and tagging approach are given in <xref ref-type="supplementary-material" rid="pgen.1002322.s023">Text S1</xref>.</p>
        <p>Imputation of untyped and missing SNP genotypes was performed using MACH 1.0.16. <xref ref-type="bibr" rid="pgen.1002322-Li4">[59]</xref> For the European samples, phased haplotypes from the CEU founders of HapMap 2 were used as reference. For African American populations, a combined CEU+YRI reference panel was created that includes SNPs segregating in both CEU and YRI, as well as SNPs segregating in one panel and monomorphic and non-missing in the other. Imputation for the IBC array was performed in two steps. First, individuals with pedigree relatedness or cryptic relatedness were filtered. A subset of individuals was randomly extracted from each panel and used to generate recombination and error rate estimates for the corresponding sample. Second, these rates were used to impute all sample individuals across the entire reference panel. Before cleaning, there were an average of 246,740 (range: 245,816, 247,505) and 227,224 (range: 225,111, 229,061) imputed SNPs in the European American and African American study populations, respectively. Imputation results were then filtered at an imputation quality limit of 0.30 and a MAF threshold of 0.01, yielding 235,077 (95.3% of total) and 227,222 (96.2% of total) SNPs for analysis in European American and African American participants, respectively.</p>
      </sec>
      <sec id="s4c">
        <title>Phenotypes</title>
        <p>The clustered risk factors of interest were characterized as a six-domain phenotype: atherogenic dyslipidemia, vascular dysfunction, vascular inflammation, pro-thrombotic state, elevated plasma glucose, and central obesity (<xref ref-type="fig" rid="pgen-1002322-g001">Figure 1</xref>). These domains were constructed <italic>a priori</italic> based on a review of literature examining clustering in metabolic phenotypes, placing specific emphasis on the National Cholesterol Education Program’s Adult Treatment Panel III report <xref ref-type="bibr" rid="pgen.1002322-Treatment1">[4]</xref>, <xref ref-type="bibr" rid="pgen.1002322-Grundy3">[60]</xref>. Nineteen variables were then selected to represent one of the six domains with preference for variables measured in at least four of the contributing cohort studies or variables that were highly correlated with available measures. Measurement protocols for each variable by study are provided in <xref ref-type="supplementary-material" rid="pgen.1002322.s022">Table S21</xref>. We assessed normality, and transformations were used when variables exhibited excessive skewness or kurtosis as determined by numerical summary information and visual inspection of histograms and normal probability plots. Dimension reduction using principal components analysis was then performed for each phenotype domain separately in each race/ethnic and study population. For example, principal components for the vascular inflammation domain were calculated using the following traits: albumin, C reactive protein, fibrinogen, uric acid, and white blood cell count. Principal components were chosen so that&gt;55% of the variance for each domain was explained (<xref ref-type="supplementary-material" rid="pgen.1002322.s013">Tables S12</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s014">S13</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s015">S14</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s016">S15</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s017">S16</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s018">S17</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s019">S18</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s020">S19</xref>, <xref ref-type="supplementary-material" rid="pgen.1002322.s021">S20</xref>). This threshold was chosen because all of the first (waist circumference, pro-thrombotic state, elevated plasma glucose, and vascular dysfunction) and the sum of first and second (vascular inflammation and atherogenic dyslipidemia) principal components exceeded 55% across all studies and racial/ethnic groups.</p>
      </sec>
      <sec id="s4d">
        <title>Statistical methods</title>
        <p>For each phenotype, we fit a linear regression model relating the phenotype to the SNP genotype under the additive mode of inheritance; the model includes environmental variables (i.e., age, sex and study center) as well as the first ten principal components from EIGENSTRAT to adjust for population substructure <xref ref-type="bibr" rid="pgen.1002322-Price1">[61]</xref>. Ten population substructure components were included because each component was associated with at least one of the eight phenotypes of interest in at least one study. If the SNP genotype is not associated with any phenotype domain, then the regression coefficients for the SNP genotype are zero in all eight linear models. We tested this global null hypothesis by constructing a multivariate test statistic based on the joint distribution of the score statistics from the eight linear models, which accounted for the correlation between the eight phenotypes. We chose the score statistic because it is computationally efficient and numerically stable. The test statistic is referred to the chi-squared distribution with eight degrees of freedom. The genome-wide significance level was set as <italic>P</italic>&lt;2.13×10<sup>−7</sup> (i.e. 0.05/235,077). Q-Q plots by race are not presented, as our use of a gene-centric array highly enriched for metabolic loci complicated the identification of markers with low prior probabilities of association (i.e. “null markers”) for all phenotypes of interest. The data from each cohort were analyzed separately and the results were combined via meta-analysis as described in <xref ref-type="supplementary-material" rid="pgen.1002322.s024">Text S2</xref>. All analyses were stratified by race and were performed in SAS 9.1 and C++. Further details are given in the <xref ref-type="supplementary-material" rid="pgen.1002322.s024">Text S2</xref>.</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pgen.1002322.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>Forest plots of univariate effect estimates and 95% confidence intervals for eight metabolic dimensions in n = 19,468 European American participants from five cohorts.</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s002" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>Baseline characteristics of ARIC Study participants (N = 11,757) by race.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s003" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s003" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <p>Baseline characteristics of CARDIA Study participants (N = 2,712) by race.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s004" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s004" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <p>Baseline characteristics of CHS Study participants (N = 4,627) by race.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s005" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s005" xlink:type="simple">
        <label>Table S4</label>
        <caption>
          <p>Baseline characteristics of Framingham Heart Study participants (N = 2,789).</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s006" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s006" xlink:type="simple">
        <label>Table S5</label>
        <caption>
          <p>Baseline characteristics of MESA Study participants (N = 3,870) by race.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s007" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s007" xlink:type="simple">
        <label>Table S6</label>
        <caption>
          <p>Pearson correlation coefficient estimates for 8 principal components used to characterize the six metabolic domains in n = 9,068 European American ARIC participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s008" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s008" xlink:type="simple">
        <label>Table S7</label>
        <caption>
          <p>Pearson correlation coefficient estimates for 8 principal components used to characterize the six metabolic domains in n = 2,689 African American ARIC participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s009" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s009" xlink:type="simple">
        <label>Table S8</label>
        <caption>
          <p>Pearson correlation coefficient estimates for 19 phenotypes used to characterize the six metabolic domains in n = 9,068 European American ARIC participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s010" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s010" xlink:type="simple">
        <label>Table S9</label>
        <caption>
          <p>Pearson correlation coefficient estimates for 19 phenotypes used to characterize the six metabolic domains in n = 2,689 African American ARIC participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s011" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s011" xlink:type="simple">
        <label>Table S10</label>
        <caption>
          <p>Overall and study-specific multivariate <italic>P-</italic>values for 19 known, confirmed, or possible new loci for metabolic trait dimensions in n = 19,468 European American from five studies.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s012" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s012" xlink:type="simple">
        <label>Table S11</label>
        <caption>
          <p>Fifteen potential secondary signals for metabolic trait dimensions in n = 19,468 European Americans from five studies.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s013" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s013" xlink:type="simple">
        <label>Table S12</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 9,068 European American ARIC participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s014" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s014" xlink:type="simple">
        <label>Table S13</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 2,712 African American ARIC participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s015" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s015" xlink:type="simple">
        <label>Table S14</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 1,433 CARDIA European American participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s016" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s016" xlink:type="simple">
        <label>Table S15</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 1,279 CARDIA African American participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s017" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s017" xlink:type="simple">
        <label>Table S16</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 3,892 European American CHS participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s018" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s018" xlink:type="simple">
        <label>Table S17</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 735 African American CHS participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s019" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s019" xlink:type="simple">
        <label>Table S18</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 2,789 European American FHS participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s020" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s020" xlink:type="simple">
        <label>Table S19</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 2,286 European American MESA participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s021" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s021" xlink:type="simple">
        <label>Table S20</label>
        <caption>
          <p>Percent variance explained by principal components used to characterize the metabolic trait dimensions, estimated in n = 1,584 African American MESA participants.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s022" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s022" xlink:type="simple">
        <label>Table S21</label>
        <caption>
          <p>Measurement protocols for 19 phenotypes used to measure metabolic trait dimensions by study.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s023" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s023" xlink:type="simple">
        <label>Text S1</label>
        <caption>
          <p>Supplemental methods.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pgen.1002322.s024" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pgen.1002322.s024" xlink:type="simple">
        <label>Text S2</label>
        <caption>
          <p>Participating studies.</p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pgen.1002322-Isomaa1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Isomaa</surname><given-names>B</given-names></name><name name-style="western"><surname>Almgren</surname><given-names>P</given-names></name><name name-style="western"><surname>Tuomi</surname><given-names>T</given-names></name><name name-style="western"><surname>Forsen</surname><given-names>B</given-names></name><name name-style="western"><surname>Lahti</surname><given-names>K</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Cardiovascular morbidity and mortality associated with the metabolic syndrome.</article-title>             <source>Diabetes Care</source>             <volume>24</volume>             <fpage>683</fpage>             <lpage>689</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Grundy1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Grundy</surname><given-names>SM</given-names></name></person-group>             <year>2006</year>             <article-title>Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy.</article-title>             <source>Nat Rev Drug Discov</source>             <volume>5</volume>             <fpage>295</fpage>             <lpage>309</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Alberti1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alberti</surname><given-names>KG</given-names></name><name name-style="western"><surname>Zimmet</surname><given-names>P</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>J</given-names></name></person-group>             <year>2006</year>             <article-title>Metabolic syndrome–a new world-wide definition. A Consensus Statement from the International Diabetes Federation.</article-title>             <source>Diabet Med</source>             <volume>23</volume>             <fpage>469</fpage>             <lpage>480</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Treatment1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Treatment</surname><given-names>PanelATP</given-names><suffix>III</suffix></name></person-group>             <year>2002</year>             <article-title>Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.</article-title>             <source>Circulation</source>             <volume>106</volume>             <fpage>3143</fpage>             <lpage>3421</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Balkau1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Balkau</surname><given-names>B</given-names></name><name name-style="western"><surname>Charles</surname><given-names>MA</given-names></name></person-group>             <year>1999</year>             <article-title>Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR).</article-title>             <source>Diabet Med</source>             <volume>16</volume>             <fpage>442</fpage>             <lpage>443</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Einhorn1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Einhorn</surname><given-names>D</given-names></name><name name-style="western"><surname>Reaven</surname><given-names>GM</given-names></name><name name-style="western"><surname>Cobin</surname><given-names>RH</given-names></name><name name-style="western"><surname>Ford</surname><given-names>E</given-names></name><name name-style="western"><surname>Ganda</surname><given-names>OP</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>American College of Endocrinology position statement on the insulin resistance syndrome.</article-title>             <source>Endocr Pract</source>             <volume>9</volume>             <fpage>237</fpage>             <lpage>252</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Grundy2">
        <label>7</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Grundy</surname><given-names>SM</given-names></name><name name-style="western"><surname>Cleeman</surname><given-names>JI</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>SR</given-names></name><name name-style="western"><surname>Donato</surname><given-names>KA</given-names></name><name name-style="western"><surname>Eckel</surname><given-names>RH</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.</article-title>             <source>Circulation</source>             <volume>112</volume>             <fpage>2735</fpage>             <lpage>2752</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-BosyWestphal1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bosy-Westphal</surname><given-names>A</given-names></name><name name-style="western"><surname>Onur</surname><given-names>S</given-names></name><name name-style="western"><surname>Geisler</surname><given-names>C</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>A</given-names></name><name name-style="western"><surname>Korth</surname><given-names>O</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study.</article-title>             <source>Int J Obes (Lond)</source>             <volume>31</volume>             <fpage>784</fpage>             <lpage>790</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Lin1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>HF</given-names></name><name name-style="western"><surname>Boden-Albala</surname><given-names>B</given-names></name><name name-style="western"><surname>Juo</surname><given-names>SH</given-names></name><name name-style="western"><surname>Park</surname><given-names>N</given-names></name><name name-style="western"><surname>Rundek</surname><given-names>T</given-names></name><etal/></person-group>             <year>2005</year>             <article-title>Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.</article-title>             <source>Diabetologia</source>             <volume>48</volume>             <fpage>2006</fpage>             <lpage>2012</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Zabaneh1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zabaneh</surname><given-names>D</given-names></name><name name-style="western"><surname>Balding</surname><given-names>DJ</given-names></name></person-group>             <year>2010</year>             <article-title>A genome-wide association study of the metabolic syndrome in Indian Asian men.</article-title>             <source>PLoS ONE</source>             <volume>5</volume>             <fpage>e11961</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0011961" xlink:type="simple">10.1371/journal.pone.0011961</ext-link></comment>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Kraja1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kraja</surname><given-names>AT</given-names></name><name name-style="western"><surname>Vaidya</surname><given-names>D</given-names></name><name name-style="western"><surname>Pankow</surname><given-names>JS</given-names></name><name name-style="western"><surname>Goodarzi</surname><given-names>MO</given-names></name><name name-style="western"><surname>Assimes</surname><given-names>TL</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium.</article-title>             <source>Diabetes</source>             <volume>60</volume>             <fpage>1329</fpage>             <lpage>1339</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Muller1">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bosy-Westphal</surname><given-names>A</given-names></name><name name-style="western"><surname>Krawczak</surname><given-names>M</given-names></name></person-group>             <year>2010</year>             <article-title>Genetic studies of common types of obesity: a critique of the current use of phenotypes.</article-title>             <source>Obes Rev</source>             <volume>11</volume>             <fpage>612</fpage>             <lpage>618</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Houle1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Houle</surname><given-names>D</given-names></name><name name-style="western"><surname>Govindaraju</surname><given-names>DR</given-names></name><name name-style="western"><surname>Omholt</surname><given-names>S</given-names></name></person-group>             <year>2010</year>             <article-title>Phenomics: the next challenge.</article-title>             <source>Nat Rev Genet</source>             <volume>11</volume>             <fpage>855</fpage>             <lpage>866</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Hegele1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>             <year>2004</year>             <article-title>Phenomics, lipodystrophy, and the metabolic syndrome.</article-title>             <source>Trends Cardiovasc Med</source>             <volume>14</volume>             <fpage>133</fpage>             <lpage>137</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Bilder1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bilder</surname><given-names>RM</given-names></name><name name-style="western"><surname>Sabb</surname><given-names>FW</given-names></name><name name-style="western"><surname>Cannon</surname><given-names>TD</given-names></name><name name-style="western"><surname>London</surname><given-names>ED</given-names></name><name name-style="western"><surname>Jentsch</surname><given-names>JD</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Phenomics: The systematic study of phenotypes on a genome-wide scale.</article-title>             <source>Neuroscience</source>             <volume>164</volume>             <fpage>30</fpage>             <lpage>42</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Amos1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Amos</surname><given-names>CI</given-names></name><name name-style="western"><surname>Laing</surname><given-names>AE</given-names></name></person-group>             <year>1993</year>             <article-title>A comparison of univariate and multivariate tests for genetic linkage.</article-title>             <source>Genet Epidemiol</source>             <volume>10</volume>             <fpage>671</fpage>             <lpage>676</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Jiang1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>C</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>ZB</given-names></name></person-group>             <year>1995</year>             <article-title>Multiple trait analysis of genetic mapping for quantitative trait loci.</article-title>             <source>Genetics</source>             <volume>140</volume>             <fpage>1111</fpage>             <lpage>1127</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Bilder2">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bilder</surname><given-names>RM</given-names></name></person-group>             <year>2008</year>             <article-title>Phenomics: building scaffolds for biological hypotheses in the post-genomic era.</article-title>             <source>Biol Psychiatry</source>             <volume>63</volume>             <fpage>439</fpage>             <lpage>440</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Freimer1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Freimer</surname><given-names>N</given-names></name><name name-style="western"><surname>Sabatti</surname><given-names>C</given-names></name></person-group>             <year>2003</year>             <article-title>The human phenome project.</article-title>             <source>Nat Genet</source>             <volume>34</volume>             <fpage>15</fpage>             <lpage>21</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Smith1">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>NL</given-names></name><name name-style="western"><surname>Chen</surname><given-names>MH</given-names></name><name name-style="western"><surname>Dehghan</surname><given-names>A</given-names></name><name name-style="western"><surname>Strachan</surname><given-names>DP</given-names></name><name name-style="western"><surname>Basu</surname><given-names>S</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.</article-title>             <source>Circulation</source>             <volume>121</volume>             <fpage>1382</fpage>             <lpage>1392</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Dupuis1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dupuis</surname><given-names>J</given-names></name><name name-style="western"><surname>Langenberg</surname><given-names>C</given-names></name><name name-style="western"><surname>Prokopenko</surname><given-names>I</given-names></name><name name-style="western"><surname>Saxena</surname><given-names>R</given-names></name><name name-style="western"><surname>Soranzo</surname><given-names>N</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.</article-title>             <source>Nat Genet</source>             <volume>42</volume>             <fpage>105</fpage>             <lpage>116</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Waterworth1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Waterworth</surname><given-names>DM</given-names></name><name name-style="western"><surname>Ricketts</surname><given-names>SL</given-names></name><name name-style="western"><surname>Song</surname><given-names>K</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>JH</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Genetic variants influencing circulating lipid levels and risk of coronary artery disease.</article-title>             <source>Arterioscler Thromb Vasc Biol</source>             <volume>30</volume>             <fpage>2264</fpage>             <lpage>2276</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Ridker1">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></name><name name-style="western"><surname>Pare</surname><given-names>G</given-names></name><name name-style="western"><surname>Parker</surname><given-names>A</given-names></name><name name-style="western"><surname>Zee</surname><given-names>RY</given-names></name><name name-style="western"><surname>Danik</surname><given-names>JS</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.</article-title>             <source>Am J Hum Genet</source>             <volume>82</volume>             <fpage>1185</fpage>             <lpage>1192</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Kamatani1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kamatani</surname><given-names>Y</given-names></name><name name-style="western"><surname>Matsuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Okada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kubo</surname><given-names>M</given-names></name><name name-style="western"><surname>Hosono</surname><given-names>N</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Genome-wide association study of hematological and biochemical traits in a Japanese population.</article-title>             <source>Nat Genet</source>             <volume>42</volume>             <fpage>210</fpage>             <lpage>215</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Kolz1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kolz</surname><given-names>M</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>T</given-names></name><name name-style="western"><surname>Sanna</surname><given-names>S</given-names></name><name name-style="western"><surname>Teumer</surname><given-names>A</given-names></name><name name-style="western"><surname>Vitart</surname><given-names>V</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.</article-title>             <source>PLoS Genet</source>             <volume>5</volume>             <fpage>e1000504</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000504" xlink:type="simple">10.1371/journal.pgen.1000504</ext-link></comment>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Matschinsky1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matschinsky</surname><given-names>FM</given-names></name><name name-style="western"><surname>Glaser</surname><given-names>B</given-names></name><name name-style="western"><surname>Magnuson</surname><given-names>MA</given-names></name></person-group>             <year>1998</year>             <article-title>Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities.</article-title>             <source>Diabetes</source>             <volume>47</volume>             <fpage>307</fpage>             <lpage>315</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Kathiresan1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kathiresan</surname><given-names>S</given-names></name><name name-style="western"><surname>Willer</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Peloso</surname><given-names>GM</given-names></name><name name-style="western"><surname>Demissie</surname><given-names>S</given-names></name><name name-style="western"><surname>Musunuru</surname><given-names>K</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Common variants at 30 loci contribute to polygenic dyslipidemia.</article-title>             <source>Nat Genet</source>             <volume>41</volume>             <fpage>56</fpage>             <lpage>65</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Okada1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Okada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ohmiya</surname><given-names>H</given-names></name><name name-style="western"><surname>Kumasaka</surname><given-names>N</given-names></name><name name-style="western"><surname>Kamatani</surname><given-names>Y</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus.</article-title>             <source>Hum Mol Genet</source>             <volume>20</volume>             <fpage>1224</fpage>             <lpage>1231</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Voight1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Voight</surname><given-names>BF</given-names></name><name name-style="western"><surname>Scott</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Steinthorsdottir</surname><given-names>V</given-names></name><name name-style="western"><surname>Morris</surname><given-names>AP</given-names></name><name name-style="western"><surname>Dina</surname><given-names>C</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.</article-title>             <source>Nat Genet</source>             <volume>42</volume>             <fpage>579</fpage>             <lpage>589</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Willer1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Willer</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Sanna</surname><given-names>S</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>AU</given-names></name><name name-style="western"><surname>Scuteri</surname><given-names>A</given-names></name><name name-style="western"><surname>Bonnycastle</surname><given-names>LL</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Newly identified loci that influence lipid concentrations and risk of coronary artery disease.</article-title>             <source>Nat Genet</source>             <volume>40</volume>             <fpage>161</fpage>             <lpage>169</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Kathiresan2">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kathiresan</surname><given-names>S</given-names></name><name name-style="western"><surname>Melander</surname><given-names>O</given-names></name><name name-style="western"><surname>Guiducci</surname><given-names>C</given-names></name><name name-style="western"><surname>Surti</surname><given-names>A</given-names></name><name name-style="western"><surname>Burtt</surname><given-names>NP</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.</article-title>             <source>Nat Genet</source>             <volume>40</volume>             <fpage>189</fpage>             <lpage>197</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Elliott1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Elliott</surname><given-names>P</given-names></name><name name-style="western"><surname>Chambers</surname><given-names>JC</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>R</given-names></name><name name-style="western"><surname>Hopewell</surname><given-names>JC</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.</article-title>             <source>JAMA</source>             <volume>302</volume>             <fpage>37</fpage>             <lpage>48</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Dehghan1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Dehghan</surname><given-names>A</given-names></name><name name-style="western"><surname>Dupuis</surname><given-names>J</given-names></name><name name-style="western"><surname>Barbalic</surname><given-names>M</given-names></name><name name-style="western"><surname>Bis</surname><given-names>JC</given-names></name><name name-style="western"><surname>Eiriksdottir</surname><given-names>G</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Meta-analysis of genome-wide association studies in &gt;80 000 subjects identifies multiple loci for C-reactive protein levels.</article-title>             <source>Circulation</source>             <volume>123</volume>             <fpage>731</fpage>             <lpage>738</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Li1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>WH</given-names></name><name name-style="western"><surname>Tanimura</surname><given-names>M</given-names></name><name name-style="western"><surname>Luo</surname><given-names>CC</given-names></name><name name-style="western"><surname>Datta</surname><given-names>S</given-names></name><name name-style="western"><surname>Chan</surname><given-names>L</given-names></name></person-group>             <year>1988</year>             <article-title>The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution.</article-title>             <source>J Lipid Res</source>             <volume>29</volume>             <fpage>245</fpage>             <lpage>271</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Jong1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jong</surname><given-names>MC</given-names></name><name name-style="western"><surname>Voshol</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Muurling</surname><given-names>M</given-names></name><name name-style="western"><surname>Dahlmans</surname><given-names>VE</given-names></name><name name-style="western"><surname>Romijn</surname><given-names>JA</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1.</article-title>             <source>Diabetes</source>             <volume>50</volume>             <fpage>2779</fpage>             <lpage>2785</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Soutar1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Soutar</surname><given-names>AK</given-names></name><name name-style="western"><surname>Garner</surname><given-names>CW</given-names></name><name name-style="western"><surname>Baker</surname><given-names>HN</given-names></name><name name-style="western"><surname>Sparrow</surname><given-names>JT</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>RL</given-names></name><etal/></person-group>             <year>1975</year>             <article-title>Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.</article-title>             <source>Biochemistry</source>             <volume>14</volume>             <fpage>3057</fpage>             <lpage>3064</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Li2">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Ku</surname><given-names>CY</given-names></name><name name-style="western"><surname>Farmer</surname><given-names>AA</given-names></name><name name-style="western"><surname>Cong</surname><given-names>YS</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CF</given-names></name><etal/></person-group>             <year>1998</year>             <article-title>Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs.</article-title>             <source>J Biol Chem</source>             <volume>273</volume>             <fpage>6183</fpage>             <lpage>6189</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Matheny1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matheny</surname><given-names>SA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Kortum</surname><given-names>RL</given-names></name><name name-style="western"><surname>Razidlo</surname><given-names>GL</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>RE</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP.</article-title>             <source>Nature</source>             <volume>427</volume>             <fpage>256</fpage>             <lpage>260</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Ory1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ory</surname><given-names>S</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>DK</given-names></name></person-group>             <year>2004</year>             <article-title>Signal transduction: implications for Ras-dependent ERK signaling.</article-title>             <source>Curr Biol</source>             <volume>14</volume>             <fpage>R277</fpage>             <lpage>278</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Cui1">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>R</given-names></name><name name-style="western"><surname>Kamatani</surname><given-names>Y</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Usami</surname><given-names>M</given-names></name><name name-style="western"><surname>Hosono</surname><given-names>N</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk.</article-title>             <source>Gastroenterology</source>             <volume>137</volume>             <fpage>1768</fpage>             <lpage>1775</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Barrett1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>JC</given-names></name><name name-style="western"><surname>Clayton</surname><given-names>DG</given-names></name><name name-style="western"><surname>Concannon</surname><given-names>P</given-names></name><name name-style="western"><surname>Akolkar</surname><given-names>B</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>JD</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.</article-title>             <source>Nat Genet</source>             <volume>41</volume>             <fpage>703</fpage>             <lpage>707</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Cooper1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>JD</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Smiles</surname><given-names>AM</given-names></name><name name-style="western"><surname>Plagnol</surname><given-names>V</given-names></name><name name-style="western"><surname>Walker</surname><given-names>NM</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.</article-title>             <source>Nat Genet</source>             <volume>40</volume>             <fpage>1399</fpage>             <lpage>1401</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Levy1">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Levy</surname><given-names>D</given-names></name><name name-style="western"><surname>Ehret</surname><given-names>GB</given-names></name><name name-style="western"><surname>Rice</surname><given-names>K</given-names></name><name name-style="western"><surname>Verwoert</surname><given-names>GC</given-names></name><name name-style="western"><surname>Launer</surname><given-names>LJ</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Genome-wide association study of blood pressure and hypertension.</article-title>             <source>Nat Genet</source>             <volume>41</volume>             <fpage>677</fpage>             <lpage>687</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Cho1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>YS</given-names></name><name name-style="western"><surname>Go</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Heo</surname><given-names>JY</given-names></name><name name-style="western"><surname>Oh</surname><given-names>JH</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits.</article-title>             <source>Nat Genet</source>             <volume>41</volume>             <fpage>527</fpage>             <lpage>534</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-LastresBecker1">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lastres-Becker</surname><given-names>I</given-names></name><name name-style="western"><surname>Brodesser</surname><given-names>S</given-names></name><name name-style="western"><surname>Lutjohann</surname><given-names>D</given-names></name><name name-style="western"><surname>Azizov</surname><given-names>M</given-names></name><name name-style="western"><surname>Buchmann</surname><given-names>J</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice.</article-title>             <source>Hum Mol Genet</source>             <volume>17</volume>             <fpage>1465</fpage>             <lpage>1481</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Li3">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>WD</given-names></name><name name-style="western"><surname>Dong</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Price</surname><given-names>RA</given-names></name></person-group>             <year>2004</year>             <article-title>An obesity-related locus in chromosome region 12q23-24.</article-title>             <source>Diabetes</source>             <volume>53</volume>             <fpage>812</fpage>             <lpage>820</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Berridge1">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Berridge</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Irvine</surname><given-names>RF</given-names></name></person-group>             <year>1984</year>             <article-title>Inositol trisphosphate, a novel second messenger in cellular signal transduction.</article-title>             <source>Nature</source>             <volume>312</volume>             <fpage>315</fpage>             <lpage>321</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Liao1">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Kume</surname><given-names>T</given-names></name><name name-style="western"><surname>McKay</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ihle</surname><given-names>JN</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice.</article-title>             <source>J Biol Chem</source>             <volume>277</volume>             <fpage>9335</fpage>             <lpage>9341</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-He1">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Z</given-names></name><name name-style="western"><surname>Opland</surname><given-names>DM</given-names></name><name name-style="western"><surname>Way</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Ueki</surname><given-names>K</given-names></name><name name-style="western"><surname>Bodyak</surname><given-names>N</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Regulation of vascular endothelial growth factor expression and vascularization in the myocardium by insulin receptor and PI3K/Akt pathways in insulin resistance and ischemia.</article-title>             <source>Arterioscler Thromb Vasc Biol</source>             <volume>26</volume>             <fpage>787</fpage>             <lpage>793</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Xiang1">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Xiang</surname><given-names>G</given-names></name><name name-style="western"><surname>Schuster</surname><given-names>MD</given-names></name><name name-style="western"><surname>Seki</surname><given-names>T</given-names></name><name name-style="western"><surname>Kocher</surname><given-names>AA</given-names></name><name name-style="western"><surname>Eshghi</surname><given-names>S</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Down-regulation of plasminogen activator inhibitor 1 expression promotes myocardial neovascularization by bone marrow progenitors.</article-title>             <source>J Exp Med</source>             <volume>200</volume>             <fpage>1657</fpage>             <lpage>1666</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Mouquet1">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Mouquet</surname><given-names>F</given-names></name><name name-style="western"><surname>Cuilleret</surname><given-names>F</given-names></name><name name-style="western"><surname>Susen</surname><given-names>S</given-names></name><name name-style="western"><surname>Sautiere</surname><given-names>K</given-names></name><name name-style="western"><surname>Marboeuf</surname><given-names>P</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1.</article-title>             <source>Eur Heart J</source>             <volume>30</volume>             <fpage>840</fpage>             <lpage>849</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Pollex1">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pollex</surname><given-names>RL</given-names></name><name name-style="western"><surname>Hegele</surname><given-names>RA</given-names></name></person-group>             <year>2006</year>             <article-title>Genetic determinants of the metabolic syndrome.</article-title>             <source>Nat Clin Pract Cardiovasc Med</source>             <volume>3</volume>             <fpage>482</fpage>             <lpage>489</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Meigs1">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Meigs</surname><given-names>JB</given-names></name></person-group>             <year>2000</year>             <article-title>Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors.</article-title>             <source>Am J Epidemiol 152: 908-911; discussion</source>             <volume>912</volume>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Meigs2">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Meigs</surname><given-names>JB</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>PW</given-names></name><name name-style="western"><surname>Nathan</surname><given-names>DM</given-names></name><name name-style="western"><surname>D'Agostino</surname><given-names>RB</given-names><suffix>Sr</suffix></name><name name-style="western"><surname>Williams</surname><given-names>K</given-names></name><etal/></person-group>             <year>2003</year>             <article-title>Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.</article-title>             <source>Diabetes</source>             <volume>52</volume>             <fpage>2160</fpage>             <lpage>2167</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Matise1">
        <label>55</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Matise</surname><given-names>TC</given-names></name><name name-style="western"><surname>Ambite</surname><given-names>JL</given-names></name><name name-style="western"><surname>Buyske</surname><given-names>S</given-names></name><name name-style="western"><surname>Cole</surname><given-names>SA</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>DC</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>The next PAGE in understanding complex traits: study design for analysis of Population Architecture using Genetics and Epidemiology.</article-title>             <publisher-name>Am J Epidemiol. In press</publisher-name>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Musunuru1">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Musunuru</surname><given-names>K</given-names></name><name name-style="western"><surname>Lettre</surname><given-names>G</given-names></name><name name-style="western"><surname>Young</surname><given-names>T</given-names></name><name name-style="western"><surname>Farlow</surname><given-names>DN</given-names></name><name name-style="western"><surname>Pirruccello</surname><given-names>JP</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Candidate gene association resource (CARe): design, methods, and proof of concept.</article-title>             <source>Circ Cardiovasc Genet</source>             <volume>3</volume>             <fpage>267</fpage>             <lpage>275</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Pendergrass1">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Pendergrass</surname><given-names>SA</given-names></name><name name-style="western"><surname>Brown-Gentry</surname><given-names>KD</given-names></name><name name-style="western"><surname>Dudek</surname><given-names>S</given-names></name><name name-style="western"><surname>Ambite</surname><given-names>JL</given-names></name><name name-style="western"><surname>Avery</surname><given-names>CL</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Phenotype-wide association study (PheWAS) for exploration of novel SNP and phenotype relationships within PAGE.</article-title>             <source>Genet Epidemiol</source>             <volume>35</volume>             <fpage>410</fpage>             <lpage>422</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Keating1">
        <label>58</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Keating</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Tischfield</surname><given-names>S</given-names></name><name name-style="western"><surname>Murray</surname><given-names>SS</given-names></name><name name-style="western"><surname>Bhangale</surname><given-names>T</given-names></name><name name-style="western"><surname>Price</surname><given-names>TS</given-names></name><etal/></person-group>             <year>2008</year>             <article-title>Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies.</article-title>             <source>PLoS ONE</source>             <volume>3</volume>             <fpage>e3583</fpage>             <comment>doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0003583" xlink:type="simple">10.1371/journal.pone.0003583</ext-link></comment>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Li4">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Willer</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><name name-style="western"><surname>Scheet</surname><given-names>P</given-names></name><name name-style="western"><surname>Abecasis</surname><given-names>GR</given-names></name></person-group>             <year>2010</year>             <article-title>MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes.</article-title>             <source>Genet Epidemiol</source>             <volume>34</volume>             <fpage>816</fpage>             <lpage>834</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Grundy3">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Grundy</surname><given-names>SM</given-names></name><name name-style="western"><surname>Brewer</surname><given-names>HB</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Cleeman</surname><given-names>JI</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SC</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Lenfant</surname><given-names>C</given-names></name></person-group>             <year>2004</year>             <article-title>Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.</article-title>             <source>Circulation</source>             <volume>109</volume>             <fpage>433</fpage>             <lpage>438</lpage>          </element-citation>
      </ref>
      <ref id="pgen.1002322-Price1">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Price</surname><given-names>AL</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Plenge</surname><given-names>RM</given-names></name><name name-style="western"><surname>Weinblatt</surname><given-names>ME</given-names></name><name name-style="western"><surname>Shadick</surname><given-names>NA</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Principal components analysis corrects for stratification in genome-wide association studies.</article-title>             <source>Nat Genet</source>             <volume>38</volume>             <fpage>904</fpage>             <lpage>909</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>